LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today

AgeneBio

Drug that normalizes abhorrent activity in the hippocampus to treat/prevent Mild Cognitive Impairment (MCI), early Alzheimer\'s disease (AD), and othe....

Get a Demo and See the Full Profile

Get a demo today to see profiles of AgeneBio plus 6123 other startups.

Learn More About AgeneBio

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More